APEA PMHNP EXAM TEST BANK 2026
REAL BOARD QUESTIONS WITH
COMPLETE VERIFIED ANSWERS &
EXPLANATIONS GRADED A+
This comprehensive PMHNP practice exam bundle
features high-yield, board-style multiple-choice
questions specifically updated for the 2026
certification blueprints. Every question is
immediately followed by its verified correct answer
and a deeply detailed, bolded clinical rationale
covering psychopharmacology, DSM-5-TR
diagnostics, and advanced practice nursing policies.
It serves as an exceptional, turn-key study guide
engineered to maximize score outcomes on the
APEA, ANCC, and AANPCB board exams
Question 1
A 28-year-old female patient presents with acute onset of severe
anxiety, palpitations, and sweating. Her laboratory results reveal a
Thyroid Stimulating Hormone (TSH) level of 0.1 mIU/L (Normal: 0.4–4.0
mIU/L) and elevated Free T4. Which of the following is the most
,appropriate next step?
A. Initiate Fluoxetine 20 mg daily
B. Initiate Alprazolam 0.5 mg as needed
C. Refer to endocrinology for suspected hyperthyroidism
D. Diagnose Generalized Anxiety Disorder (GAD)
Answer: C
Rationale: The patient’s lab values demonstrate primary
hyperthyroidism (low TSH, high Free T4), which directly mimics panic
and anxiety symptoms. It is vital to rule out and treat underlying
medical conditions before diagnosing a primary psychiatric disorder.
Initiating psychiatric medications without addressing the endocrine
pathology is inappropriate.
Question 2
A PMHNP is considering putting a patient on Clozapine for treatment-
resistant schizophrenia. Which baseline absolute neutrophil count
(ANC) is required to safely initiate this medication?
A. ≥ 1,000/µL
B. ≥ 1,500/µL
C. ≥ 2,000/µL
D. ≥ 2,500/µL
Answer: B
Rationale: According to the Clozapine REMS program, the general
population must have a baseline Absolute Neutril count (ANC) of ≥
1,500/µL to safely initiate treatment. For patients with documented
Benign Ethnic Neutropenia (BEN), the baseline requirement is ≥
1,000/µL.
,Question 3
An 8-year-old boy is brought to the clinic for an evaluation due to
frequent outbursts, irritability, and hyperactivity at school and home.
The PMHNP wants to rule out pediatric bipolar disorder. Which clinical
feature most strongly distinguishes Disruptive Mood Dysregulation
Disorder (DMDD) from Bipolar Disorder in children?
A. The presence of hyperactive behavior
B. The irritability is chronic and persistent rather than episodic
C. The child throws intense temper tantrums
D. Symptoms occur in more than one setting
Answer: B
Rationale: DMDD is characterized by chronic, persistent, non-episodic
irritability and anger between severe temper outbursts. Bipolar
disorder in children involves distinct, episodic shifts in mood
(mania/hypomania) that represent a clear change from the child's
baseline behavior.
Question 4
Which neurodevelopmental pathway is primarily responsible for the
positive symptoms of schizophrenia, such as hallucinations and
delusions?
A. Mesocortical pathway
B. Mesolimbic pathway
C. Nigrostriatal pathway
D. Tuberoinfundibular pathway
, Answer: B
Rationale: Hyperactivity of dopamine in the mesolimbic pathway is
directly linked to the positive symptoms of schizophrenia. Conversely,
hypoactivity of dopamine in the mesocortical pathway is associated
with negative and cognitive symptoms.
Question 5
A patient taking Haloperidol develops severe muscle rigidity, a
temperature of 103.2°F (39.6°C), altered mental status, and autonomic
instability. Laboratory tests reveal a significantly elevated creatine
kinase (CK) level. Which condition is most likely occurring?
A. Serotonin Syndrome
B. Neuroleptic Malignant Syndrome (NMS)
C. Acute Dystonia
D. Anticholinergic Toxicity
Answer: B
Rationale: NMS is a life-threatening complication of antipsychotic use
characterized by "lead-pipe" muscle rigidity, hyperthermia, autonomic
instability, and elevated CK levels. Serotonin syndrome features
hyperreflexia and clonus rather than lead-pipe rigidity, and is caused
by serotonergic agents.
Question 6
A 34-year-old male diagnosed with Major Depressive Disorder has failed
two trials of selective serotonin reuptake inhibitors (SSRIs). The PMHNP
decides to switch the patient to Phenelzine, a Monoamine Oxidase
REAL BOARD QUESTIONS WITH
COMPLETE VERIFIED ANSWERS &
EXPLANATIONS GRADED A+
This comprehensive PMHNP practice exam bundle
features high-yield, board-style multiple-choice
questions specifically updated for the 2026
certification blueprints. Every question is
immediately followed by its verified correct answer
and a deeply detailed, bolded clinical rationale
covering psychopharmacology, DSM-5-TR
diagnostics, and advanced practice nursing policies.
It serves as an exceptional, turn-key study guide
engineered to maximize score outcomes on the
APEA, ANCC, and AANPCB board exams
Question 1
A 28-year-old female patient presents with acute onset of severe
anxiety, palpitations, and sweating. Her laboratory results reveal a
Thyroid Stimulating Hormone (TSH) level of 0.1 mIU/L (Normal: 0.4–4.0
mIU/L) and elevated Free T4. Which of the following is the most
,appropriate next step?
A. Initiate Fluoxetine 20 mg daily
B. Initiate Alprazolam 0.5 mg as needed
C. Refer to endocrinology for suspected hyperthyroidism
D. Diagnose Generalized Anxiety Disorder (GAD)
Answer: C
Rationale: The patient’s lab values demonstrate primary
hyperthyroidism (low TSH, high Free T4), which directly mimics panic
and anxiety symptoms. It is vital to rule out and treat underlying
medical conditions before diagnosing a primary psychiatric disorder.
Initiating psychiatric medications without addressing the endocrine
pathology is inappropriate.
Question 2
A PMHNP is considering putting a patient on Clozapine for treatment-
resistant schizophrenia. Which baseline absolute neutrophil count
(ANC) is required to safely initiate this medication?
A. ≥ 1,000/µL
B. ≥ 1,500/µL
C. ≥ 2,000/µL
D. ≥ 2,500/µL
Answer: B
Rationale: According to the Clozapine REMS program, the general
population must have a baseline Absolute Neutril count (ANC) of ≥
1,500/µL to safely initiate treatment. For patients with documented
Benign Ethnic Neutropenia (BEN), the baseline requirement is ≥
1,000/µL.
,Question 3
An 8-year-old boy is brought to the clinic for an evaluation due to
frequent outbursts, irritability, and hyperactivity at school and home.
The PMHNP wants to rule out pediatric bipolar disorder. Which clinical
feature most strongly distinguishes Disruptive Mood Dysregulation
Disorder (DMDD) from Bipolar Disorder in children?
A. The presence of hyperactive behavior
B. The irritability is chronic and persistent rather than episodic
C. The child throws intense temper tantrums
D. Symptoms occur in more than one setting
Answer: B
Rationale: DMDD is characterized by chronic, persistent, non-episodic
irritability and anger between severe temper outbursts. Bipolar
disorder in children involves distinct, episodic shifts in mood
(mania/hypomania) that represent a clear change from the child's
baseline behavior.
Question 4
Which neurodevelopmental pathway is primarily responsible for the
positive symptoms of schizophrenia, such as hallucinations and
delusions?
A. Mesocortical pathway
B. Mesolimbic pathway
C. Nigrostriatal pathway
D. Tuberoinfundibular pathway
, Answer: B
Rationale: Hyperactivity of dopamine in the mesolimbic pathway is
directly linked to the positive symptoms of schizophrenia. Conversely,
hypoactivity of dopamine in the mesocortical pathway is associated
with negative and cognitive symptoms.
Question 5
A patient taking Haloperidol develops severe muscle rigidity, a
temperature of 103.2°F (39.6°C), altered mental status, and autonomic
instability. Laboratory tests reveal a significantly elevated creatine
kinase (CK) level. Which condition is most likely occurring?
A. Serotonin Syndrome
B. Neuroleptic Malignant Syndrome (NMS)
C. Acute Dystonia
D. Anticholinergic Toxicity
Answer: B
Rationale: NMS is a life-threatening complication of antipsychotic use
characterized by "lead-pipe" muscle rigidity, hyperthermia, autonomic
instability, and elevated CK levels. Serotonin syndrome features
hyperreflexia and clonus rather than lead-pipe rigidity, and is caused
by serotonergic agents.
Question 6
A 34-year-old male diagnosed with Major Depressive Disorder has failed
two trials of selective serotonin reuptake inhibitors (SSRIs). The PMHNP
decides to switch the patient to Phenelzine, a Monoamine Oxidase
